Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Health & Life Sciences

Overview

As a stakeholder in the health and life sciences sector, you work every day to improve human health and enhance patient care. Our national health and life sciences team partners with industry leaders like you — biotech innovators, pharmaceutical and medical device manufacturers, health systems, investors, and digital health pioneers — to help you thrive in a landscape defined by rapid change and increasingly complex regulatory demands.

Our professionals have extensive practical experience to help you navigate the sector’s most critical business and legal challenges. We advise on transformative mergers and acquisitions, strategic investments, and capital deployment, ensuring your transactions are efficient and positioned for long-term growth and innovation. Our team handles high-stakes litigation and government investigations, providing sophisticated advocacy and clear strategic guidance when challenges arise.

We support you throughout the business life cycle — structuring and negotiating technology transactions, licensing, and collaborations; guiding you through complex regulatory requirements at all stages of the product lifecycle; and implementing proactive risk management and compliance solutions. Our capabilities also encompass employee benefits and executive compensation, privacy and data security, outsourcing, intellectual property, and public policy strategy, helping you seize opportunities and mitigate risk in every aspect of your operations.

Our team includes former in-house counsel to major health systems and global life sciences companies, as well as former FDA, other federal agency and Capitol Hill health policy advisors, and former Department of Justice attorneys. With this blend of industry insight and legal acumen, we deliver practical, business-minded solutions tailored to your most complex challenges so you can continue advancing your mission and achieving your strategic objectives in a rapidly evolving sector.

Insights & Events

Latest

Updates March 2026

China Issued New Regulations to Protect Trade Secrets

New Provisions Make It Easier for IPR Holders to Protect Trade Secrets through Market Regulatory Authorities in China
8 min read
Updates March 2026

Federal Appellate Courts Continue to Require That Trade Secrets Be Defined and Definite

Applied Predictive Technologies v. MarketDial; Coda Development v. Goodyear; Quintara Biosciences v. Ruifeng Biztech; Sysco Machinery v. DCS USA
6 min read
Press Release March 2026

Health Care Attorney Isaac Willett Rejoins Faegre Drinker in Indianapolis

2 min read
Updates March 2026

Access through Innovation with Amazon Pharmacy

Digital Health “From the Inside Out” Leadership Series
2 min read
Updates March 2026

FDA Finalizes Rule Requiring 12-Digit National Drug Code (NDC)

Two Little Digits, One Very Big Operational Headache
4 min read
Updates February 2026

UK Data (Use and Access) Act 2025: Update and New Compliance Challenges

“Right to Complain” will come into force 19 June 2026
6 min read
Updates February 2026

FDA Publishes Long-Awaited Draft Guidance on “Plausible Mechanism Framework” to Spur the Development of New Individualized Medicines

Anticipated Deadline for Comments Is April 27, 2026
7 min read
News February 2026

Jessica Natali Honored With Temple Law’s 2026 Women’s Law Caucus Leadership Award

1 min read
Speaking Engagement Recap November 08, 2025

The Impact of AI on the Pharmacy Industry: Managing its Risks and Benefits

American Society for Pharmacy Law: 2025 Developments in Pharmacy Law
1 min read
Speaking Engagement Recap November 07, 2025

Data, Dangers, & Developments in Drug Supply Chain Security & Safety

American Society for Pharmacy Law: 2025 Developments in Pharmacy Law
1 min read
Insights
Updates March 2026

China Issued New Regulations to Protect Trade Secrets

New Provisions Make It Easier for IPR Holders to Protect Trade Secrets through Market Regulatory Authorities in China
8 min read
Updates March 2026

Federal Appellate Courts Continue to Require That Trade Secrets Be Defined and Definite

Applied Predictive Technologies v. MarketDial; Coda Development v. Goodyear; Quintara Biosciences v. Ruifeng Biztech; Sysco Machinery v. DCS USA
6 min read
Updates March 2026

Access through Innovation with Amazon Pharmacy

Digital Health “From the Inside Out” Leadership Series
2 min read
Updates March 2026

FDA Finalizes Rule Requiring 12-Digit National Drug Code (NDC)

Two Little Digits, One Very Big Operational Headache
4 min read
Updates February 2026

UK Data (Use and Access) Act 2025: Update and New Compliance Challenges

“Right to Complain” will come into force 19 June 2026
6 min read
Updates February 2026

FDA Publishes Long-Awaited Draft Guidance on “Plausible Mechanism Framework” to Spur the Development of New Individualized Medicines

Anticipated Deadline for Comments Is April 27, 2026
7 min read
Updates February 2026

UK Supreme Court Sets New Standard for AI Patentability in Emotional Perception Decision

Emotional Perception AI Ltd v Comptroller General of Patents, Designs and Trade Marks [2026] UKSC 3
9 min read
Media Mentions February 2026

Mollie Sitkowski Comments on Supreme Court’s Ruling Blocking Tariffs Under IEEPA

2 min read
Published Articles February 2026

What to Know About Indiana’s New Data Protection Law

Indianapolis Business Journal
1 min read
Media Mentions February 2026

Mollie Sitkowski Discusses Tariff Loophole Fix With Endpoints News

1 min read

Meet The Team

Meet The Full Health & Life Sciences Team